Stay updated on Apremilast in Nummular Eczema Clinical Trial
Sign up to get notified when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.

Latest updates to the Apremilast in Nummular Eczema Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedSite revision updated to v3.4.2. The prior revision notice (v3.4.1) and the funding/status notice were removed.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding status and updated the page version to v3.4.1, replacing the prior v3.4.0 note.SummaryDifference0.5%

- Check28 days agoChange DetectedIntroduced a Show glossary option and added new metadata entries: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the older entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now shown, replacing v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedA dedicated Locations section was added, listing Bavaria as a study site, and the page revision updated to v3.3.3. The older grouping 'Bavaria Locations' was removed along with the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page now displays a new revision header 'Revision: v3.3.2' replacing the previous 'Revision: v3.2.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Apremilast in Nummular Eczema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.